文献速递流行病学与生物统计医学教育与科研方法

中国学者英文发表系统综述与Meta分析方法学及报告质量高于中文发表

Clinical Epidemiology in China series. Paper 3: The methodological and reporting quality of systematic reviews and meta-analyses published by China' researchers in English-language is higher than those published in Chinese-language.
PubMed 文献 · J Clin Epidemiol · 2021-08-18

该研究评估2016至2018年中国作者发表的英文和中文系统综述与Meta分析(SRs/MAs)的方法学与报告质量。随机抽取CSCD中文文献并匹配MEDLINE英文文献各168篇,用PRISMA和AMSTAR-2评价。英文SRs/MAs的PRISMA和AMSTAR-2平均分均略高于中文,但两者在方案注册、检索策略和基金来源报告等条目上依从性均低。

要点

  • 英文SRs/MAs的PRISMA和AMSTAR-2平均分均略高于中文。
  • 不足半数SRs/MAs报告方案注册、信息来源、检索策略和基金。
  • 仅0.6%中文和5.4%英文SRs/MAs被评为高质量。

核心结论

  • 2016至2018年中国作者英文发表的SRs/MAs报告和方法学质量略优于中文发表。

研究设计与样本

  • 检索MEDLINE和CSCD,随机抽取每年10%的中文SRs/MAs并匹配等量英文SRs/MAs,共336篇(中英文各168篇)。
  • 使用PRISMA评估报告质量,AMSTAR-2评估方法学质量,并进行分层分析比较中英文差异。

主要发现

  • 中文SRs/MAs的PRISMA平均分略低于英文:2016年20.58 vs. 21.71,2017年19.87 vs. 21.24,2018年21.29 vs. 22.38。
  • 中文SRs/MAs的AMSTAR-2平均分略低于英文:2016年8.07 vs. 9.36,2017年9.21 vs. 10.26,2018年8.86 vs. 9.28。
  • 中英文SRs/MAs中遵守PRISMA第5、7、8、27条的比例均不足一半。
  • 中英文SRs/MAs中遵守AMSTAR-2第2、4、10条的比例均低于10%。
  • 仅1篇(0.6%)中文和9篇(5.4%)英文SRs/MAs被评为高质量。

临床怎么用

  • 中国作者发表SRs/MAs时应加强方案注册、全面检索和基金来源报告。
  • 期刊和读者可参考PRISMA和AMSTAR-2条目关注SRs/MAs的关键报告缺陷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the methodological and reporting quality of Chinese- and English -language systematic reviews and meta-analyses (SRs/MAs) published by Chinese authors between 2016 and 2018. STUDY DESIGN AND SETTING: We searched MEDLINE and Chinese Science Citation Database (CSCD) for SRs/MAs led by Chinese authors published between 2016 and 2018. We used random sampling to select 10% of the eligible SRs/MAs published in each year from CSCD, and then matched the same number of SRs/MAs in MEDLINE. Reporting quality was evaluated using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and methodological quality using the Assessment of Multiple Systematic Reviews (AMSTAR-2) tool. Stratified analyses were conducted to compare the differences of quality between Chinese- and English language SRs/MAs. RESULTS: We identified 336 SRs/MAs (168 in Chinese and 168 in English). The reporting quality in Chinese-language SRs/MAs was slightly lower than English-language SRs/MAs (mean PRISMA scores: 20.58 vs. 21.71 in 2016, 19.87 vs. 21.24 in 2017, and 21.29 vs. 22.38 in 2018). Less than half of both Chinese- and English-language SRs/MAs complied with item 5 (protocol and registration), item 7 (information sources), item 8 (search) and item 27 (funding)). The methodological quality in Chinese -language SRs/MAs was also slightly lower than English -language SRs/MAs (mean AMSTAR-2 scores: 8.07 vs. 9.36 in 2016; 9.21 vs. 10.26 in 2017; 8.86 vs. 9.28 in 2018). Three items (item 2: established a protocol; item 4: use a comprehensive literature search; and item 10: report the sources of funding) were adhered to by less than 10% of both Chinese- and English -language SRs/MAs. Only one (0.6%) Chinese-language SRs/MA and nine (5.4%) English-language SRs/MAs were rated as high methodological quality. CONCLUSION: The reporting and methodological quality of English-language SRs/MAs conducted by authors from China between 2016 and 2018 were slightly better than those of Chinese -language SRs/MAs.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Cao L, Yao L, Hui X, et al. Clinical Epidemiology in China series. Paper 3: The methodological and reporting quality of systematic reviews and meta-analyses published by China' researchers in English-language is higher than those published in Chinese-language. J Clin Epidemiol. 2021. PMID: 34418547. doi:10.1016/j.jclinepi.2021.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。